午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook
Chinese English Germany Korean

ShangHai Biochempartner Co.,Ltd 企業(yè)の連絡先情報

名前:ShangHai Biochempartner Co.,Ltd
電話番號:177-54423994
電子メール:2853530910@QQ.com
國籍:China
ウェブサイト:www.biochempartner.com
商品の合計數(shù):8000
64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80

製品カタログ

Ozoralizumabオゾラリズマブ（遺伝子組換え）1167985-17-2
Drozitumab912628-39-8
Blosozumab1132758-87-2
Sirukumabシルクマブ（遺伝子組換え）1194585-53-9
Enoticumab1192578-27-0
Vandortuzumab Vedotin1471985-92-8
Amivantamabアミバンタマブ（遺伝子組換え）2171511-58-1
ML3392579689-83-9C26H32ClN3O5
INE9632640567-43-5C19H26N6O2S
Bectumomab158318-63-9
2,4-Dichlorophenoxyacetyl chloride(2,4-ジクロロフェノキシ)酢酸クロリド774-74-3C8H5Cl3O2
Mc-Val-Ala-PAB-PNP1639939-40-4C32H37N5O10
Rontalizumab948570-30-7
Dalotuzumab1005389-60-5
Icrucumab1024603-92-6
Tregalizumab1207446-68-1
Flanvotumab1188277-05-5
Clazakizumab1236278-28-6
Tafasitamab1422527-84-1
AZD-1940881413-29-2C20H29F2N3O2S
Bocidelpar2095128-20-2C25H27F3N2O3
NCC0072342583-66-6C22H28F3N7
Altumomabアルツモマブ156586-92-4
Lirilumab1000676-41-4
Sifalimumab1006877-41-3
Enokizumab909875-08-7
Onartuzumabオナルツズマブ（遺伝子組換え）1133766-06-9
Indatuximab Ravtansine1238517-16-2
Quilizumab1228538-47-3
Tesidolumab1531594-08-7
AZ322288709-96-4C20H16N4O
JYN423461903742-34-6C27H24BrN7O3
Maslimomab127757-92-0
Faralimomab167816-91-3
Minretumomab195189-17-4
Samalizumab1073059-33-2
Vepalimomab195158-85-1
Ensituximab1092658-06-4
Atinumab1226761-65-4
Crenezumabクレネズマブ（遺伝子組換え）1095207-05-8
Tabalumabタバルマブ（遺伝子組換え)1143503-67-6
Fasinumabファシヌマブ（遺伝子組換え）1190239-42-9
Lacutamab2187368-16-5
Indusatumab Vedotin1514889-12-3
NCGC00378430920650-00-6C22H23N3O5S
Apostatin-12559703-06-7C19H27N3OS
Nerelimomab162774-06-3
Mavrilimumab1085337-57-0
Olokizumab1007223-17-7
Ublituximab1174014-05-1
Narnatumab1188275-92-4
Demcizumab1243262-17-0
Imgatuzumab959963-46-3
Lokivetmab1533403-95-0
GI 1817713-[3-[1-[2-オキソ-2-(イソプロピルフェニルアミノ)エチル]-2,4-ジオキソ-5-フェニル-2,3,4,5-テトラヒドロ-1H-1,5-ベンゾジアゼピン-3α-イル]ウレイド]安息香酸305366-98-7C34H31N5O6
Mogamulizumabモガムリズマブ（遺伝子組換え）1159266-37-1
Fezakinumab1007106-86-6
Suvizumab914257-21-9
Etrolizumab1044758-60-2
Ponezumab1178862-65-1
Caplacizumabカプラシズマブ（遺伝子組換え）915810-67-2
Actoxumab1245634-25-6
SUC-ALA-ALA-PRO-PHE-PNA107409-54-1C30H34N6O8
AMG-131N-[3,5-ジクロロ-4-[(3-キノリル)オキシ]フェニル]-2,4-ジクロロベンゼンスルホンアミド315224-26-1C21H12Cl4N2O3S
Morolimumab
Foralumab946415-64-1
Carlumab915404-94-3
Ficlatuzumab1174900-84-5
Vatelizumab1238217-55-4
Futuximab1310460-85-5
Andecaliximab1518996-49-0
Nemolizumab1476039-58-3
SR16644′-[5-[[(S)-1-(4-ニトロフェニル)エチル]アミノカルボニル]-2,3-ジメチル-1H-インドール-1-イルメチル]-1,1′-ビフェニル-2-カルボン酸1338259-05-4C33H29N3O5
Patritumab1262787-83-6
Rovelizumab339086-79-2
Teprotumumab1036734-93-6
Vesencumab1205533-60-3
Pateclizumab1202526-59-7
Duligotuzumab1314238-96-4
Ligelizumabリゲリズマブ（遺伝子組換え）1322627-61-1
Evinacumabエビナクマブ（遺伝子組換え）1446419-85-7
RY7851393748-80-5C21H20N4O2S
Urelumab934823-49-1
Lebrikizumabレブリキズマブ（遺伝子組換え）953400-68-5
Glembatumumab1020264-78-1
Fulranumab902141-80-4
Radretumab1253180-81-2
Inclacumab1256258-86-2
Bezlotoxumabベズロトクスマブ（遺伝子組換え）1246264-45-8
Dectrekumab1528523-94-5
SCD1 inhibitor-31282606-48-7C19H16FN7O2
Biotinyl Cystamine128915-82-2C14H26N4O2S3
Itolizumab1116433-11-4
Intetumumab725735-28-4
Girentuximab916138-87-9
Enavatuzumab1062149-33-0
Solitomab1005198-65-1
Isatuximabイサツキシマブ（遺伝子組換え）1461640-62-9
YTX-4652225824-53-1C25H26N6O3
(R)-GSK-36850322170140-50-6C22H24N6OS
64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80
Copyright 2017 ? ChemicalBook. All rights reserved